Patient drop-out remains one of the most costly and underestimated risks in clinical trials—driving delays, protocol deviations, budget inflation, and compromised data quality. Even with patient‑centric designs, DCT models, and enhanced engagement tools, most teams still detect these risks too late, after operational issues have already emerged.
Join us for a practical, business-focused webinar introducing Cognivia Signal, the first behavioral intelligence platform that enables sponsors and CROs to anticipate, monitor, and understand behavior‑related patient risks throughout the clinical trial lifecycle.
